Oral Aspirin Loading Dose for Suspected Acute Coronary Syndrome When Reperfusion Is Unavailable

Immediate Pre‑Hospital Administration

Give a loading dose of 162 – 325 mg non‑enteric‑coated aspirin, chewed immediately, to any patient with suspected acute coronary syndrome when reperfusion therapy cannot be provided and the nearest hospital is distant. The American Heart Association endorses this range for acute myocardial infarction. [1][3]
Administer aspirin as early as possible after symptom onset—ideally in the pre‑hospital setting before transport begins. Early treatment yields the greatest mortality reduction, with the benefit most pronounced when started within the first few hours of symptom onset. 1

Both 162 mg and 325 mg doses fall within the guideline‑recommended range and achieve rapid, near‑total inhibition of thromboxane A₂ production, the pharmacologic basis of aspirin’s antithrombotic effect. 1

Chew the aspirin tablet thoroughly before swallowing to ensure rapid buccal absorption and a faster antiplatelet effect. 1
Use non‑enteric‑coated formulations; enteric‑coated aspirin should be avoided in the acute setting because it significantly delays absorption. [1][3]

Do not give aspirin if any of the following are present: known aspirin allergy or hypersensitivity, active gastrointestinal bleeding, recent gastrointestinal bleeding (within days to weeks), or any signs of active bleeding/bleeding diathesis. 2

Aspirin reduces mortality in acute myocardial infarction, with the benefit occurring rapidly after administration. This effect is especially critical when reperfusion therapy is unavailable. 1
Three major trials in unstable angina have shown that aspirin lowers the combined endpoint of death or myocardial infarction. 2

After the initial loading dose, continue aspirin at 75 – 162 mg daily indefinitely for secondary prevention. 1
Once the patient reaches the hospital, the maintenance dose can be lowered to 75 – 100 mg daily to minimize bleeding risk while preserving efficacy. 3

Do not delay aspirin administration while awaiting physician consultation when the patient meets criteria and has no contraindications; each minute of delay reduces the mortality benefit. 2
Do not use enteric‑coated aspirin for the acute loading dose, as it delays absorption when rapid action is essential. [1][2]
Do not give aspirin to patients with recent bleeding, even if cardiac symptoms are severe, because re‑bleeding mortality can equal or exceed cardiac mortality. 2
Ensure the patient chews the aspirin; swallowing whole tablets postpones the antiplatelet effect. 2